• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA advisory panel to discuss ‘superbug’ scopes

FDA advisory panel to discuss ‘superbug’ scopes

March 12, 2015 By MassDevice Contributors Network

FDA advisory panel to discuss 'superbug' scopes

(Reuters) — The FDA said an advisory panel is slated to discuss the transmission of “superbug” infections through endoscopy procedures in U.S. hospitals.

A 2nd top Los Angeles hospital reported an outbreak of drug-resistant “superbug” infections last week, and dozens more potential exposures, from procedures performed with a fiber-optic instrument called duodenoscope.

The gastroenterology & urology devices panel is scheduled to meet May 14-15, the federal safety watchdog said today.

A top FDA official said earlier this month that manufacturers’ tests of procedures to clean medical scopes linked with “superbug” outbreaks contained flaws that render their cleaning instructions unreliable.

Duodenoscopes have been associated with episodic infections for more than a decade. But an increasing number of germs have developed a resistance to antibiotics, making them potentially more dangerous and difficult to treat.

A top Los Angeles hospital, Cedars-Sinai Medical Center, said last week that 4 patients had been infected with bacteria from a contaminated scope and 67 more were at risk, weeks after UCLA Ronald Reagan hospital reported 7 patients were similarly infected and scores more potentially exposed. Across the country in Connecticut, Hartford Hospital has also reported a similar outbreak involving at least five infections and more than 280 potential exposures.

Between 2013 and 2014, the FDA said it received reports of 135 possible microbial transmission from reprocessed duodenoscopes. The federal safety watchdog has been under pressure to review current protocol of sterilizing the instruments after a string of superbug outbreaks at hospitals across the country.

Although the FDA said Olympus put its TJF-Q180V duodenoscope on the market without the agency’s clearance, Olympus claimed that, based on the FDA’s policy, a modified version of its previously approved scope did not require a new marketing approval.

Top makers of the devices include Olympus, Fujifilm Holdings (TSE:4901) and Hoya Corp.‘s (TYO:7741) Pentax subsidiary.

Filed Under: Endoscopic, Food & Drug Administration (FDA), Hospital Care, News Well, Regulatory/Compliance Tagged With: Fujifilm, Olympus, Pentax

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy